CUPERTINO, Calif. (PRWEB)
June 12, 2020

Ecrio, a leading supplier of advanced 5G real time communications and messaging software, is pleased to announce the appointment of Dr. Ronjon Nag as Chairman of its Board of Directors. Ronjon joins the Board with over 30 years of experience as an inventor and entrepreneur. He is currently a Stanford Distinguished Careers Institute Interdisciplinary Fellow and the founder of R42 Institute which invents, invests and informs. Ronjon has deployed artificial intelligence systems for mobile devices over three decades, working on neural networks at Cambridge, where he received a PhD in engineering; at Stanford, where he was a Harkness Fellow; and at MIT, where he received an MS. He received the IET Mountbatten Medal at the Royal Institution for his contributions to the modern mobile phone industry. Companies he has co-founded or advised have been sold to Motorola, BlackBerry, where he held Vice-President positions, and Apple. As Chairman of Bounce Imaging, which develops tactical cameras for the defense and security industry his company was winner of the $1m Verizon Powerful Answers Prize.

“On behalf of Ecrio and the Board of Directors, I welcome Ronjon as we look forward to drawing upon his strategic and operational experience,” said Michel Gannage, Founder and CEO of Ecrio. “We are thrilled to team up with him at a critical time in our evolution as we advance in the deployment of our 5G Communication and Messaging products. His significant insights and experience in Mobile and AI will be essential while we continue to strengthen our technology assets.”

“I am delighted to have the opportunity to join the Ecrio Board of Directors as the Company targets the exciting and leading edge 5G opportunities for the smartphones, broadband and IoT markets. The FlexIMSTM technology that underpins Ecrio products is ground-breaking and I look forward to working with the management team to take the company to the next level of growth,” said Dr Nag.

About Ecrio

Ecrio is the leading supplier of advanced 5G communications and messaging software. Ecrio offers a comprehensive suite of standards compliant communications solutions including Rich Communication Services (RCS), Voice over LTE (VoLTE/VoNR), and WiFi Calling. Built on the patented FlexIMSTM Architecture, Ecrio solutions can be deployed on chip, on devices or in the cloud. Ecrio’s customers include industry Tier 1 operators, leading device makers and chipset platform providers. For more information, please visit http://www.ecrio.com

FlexIMSTM is a trademark of Ecrio Inc.

Share article on social media or email:

BASEL, Switzerland (PRWEB)
June 11, 2020

EVEX Hospitals is the group member of Georgia Healthcare Group (GHG). GHG is the largest healthcare service provider in Georgia, with 23% market share by number of referral hospitals and community clinics beds (3,320). GHG offers the most comprehensive range of inpatient and outpatient services through an integrated network of hospitals and clinics equipped with state-of-the-art equipment. EVEX Hospitals has a strong background in running clinical trials, with high integrity data; productive, reliable site operations; rapid country and site startup; and established ethics compliance standards across its sites.

Joining Patient Network Explorer, EVEX Hospitals’ patients and their treating physicians gain increased treatment options and quicker access to new medical interventions. Patients will be matched to clinical studies according to their electronic health records, ensuring better screening when recruiting for clinical trials. Trial managers gain the ability to include eligible patients for trials more quickly and efficiently than before.

“We are pleased with our strong expansion in Georgia, which means we have a good representation and coverage of the country,” says Ian Rentsch, CEO of Clinerion. “This makes the services that we offer for Georgia more statistically meaningful to researchers and clinical trial managers at Pharma sponsors and CRO.”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.

Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: http://www.clinerion.com

Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/PatientNetworkExplorerSolutions.html

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

About EVEX Hospitals

EVEX Hospitals and EVEX clinics are organized in specific geographical clusters to provide medical services and high-quality care to the largest range of patients through:

• polyclinics – offering outpatient services;
• community clinics – offering broader outpatient services and a limited range of inpatient healthcare services; and
• referral hospitals – offering a comprehensive range of complex inpatient and specialist services.

The referral hierarchy within each geographical cluster provides patients with a complete and convenient treatment pathway, from local physicians in polyclinics and community clinics to referral hospitals. Our 86 specialist ambulances help achieve this by facilitating the movement of patients to and between our hospitals. While we provide basic (“primary”) medical and surgical procedures at all our facilities, the majority of more specialized or advanced (“secondary” and “tertiary”) interventional and surgical procedures are concentrated in our regional referral hospitals.

The company has strong corporate governance; standardized processes; safety and quality standards and its own personnel training center. Hospitals provide the latest treatments using technologically advanced equipment and the most up-to-date infrastructure.

EVEX Hospitals has a strong background in managing clinical trials. It has established a benchmark in terms of ethics compliance and standards across its sites. First-class leaders of our medical team are driving the improvement of service quality and access of patients to healthcare across the organization. High integrity data; productive, reliable site operations; rapid country and site startup make EVEX Hospitals the preferred clinical trial site supplier.

EVEX Hospitals website: http://www.ghg.com.ge

For more information, please contact:

Tea Tseradze

Head of Business Development Department

EVEX Hospitals

142 A. Beliashvili Str. Tbilisi 0159, Georgia

Tel.: +995 32 255 05 05

Mobile: +995 577 27 97 27

ttseradze@evex.ge

Share article on social media or email:

SEOUL, South Korea (PRWEB)
June 03, 2020

CMITech Company, a leader in cost effective, high performance iris and face recognition systems, announced today that it has launched its NovaFace face recognition system, a compact, embedded terminal for ultra-fast and user friendly biometrics authentication. The NovaFace system can be wall, turnstile or speedgate mounted, making it fully suitable for access control and T&A deployments.

Most importantly, the NovaFace system is fully contactless while operating at a stand-off distance range of 0.3 to 1.6 meters, addressing the most serious of current user concerns about hygiene and potential bio-hazard contamination. The user experience is fast and effortless; the system incorporates an innovative auto-zoom display function that enlarges the subject’s face to make positioning easier from a distance. Furthermore, the NovaFace employs the latest of AI-based (neural network) face recognition algorithms to provide the highest levels of matching accuracy.

“The biometrics industry is now urgently migrating to contactless solutions,” said Dr. JJ Chae, the CEO of CMITech. “Our new NovaFace product not only fully addresses the very serious mandate of avoiding any user contact with an authentication device, but also delivers on expectations of a great user experience—fast, smooth and effortless.“

The NovaFace product shares the same systems integration architecture as the company’s leading iris product, the EF-45, a proven approach that is easy to implement. This also means that partners who have already integrated the EF-45 will be able to add the NovaFace to their product line-up with minimal effort.

“The recent advent of neural network based face algorithms has completely changed the biometrics landscape,” said Phil Tusa, the COO of CMITech. “These algorithms deliver far superior accuracy levels than just a couple of years ago, putting face recognition on a par with the best of single fingerprint sensors. Without question, the biometrics world will now quickly migrate toward contactless face recognition solutions like the NovaFace.”

About CMITech Company, Ltd.

CMITech is a leading developer of high performance, cost effective iris and face recognition systems for the global biometrics and secure identity assurance markets. Founded in 2009 by Dr. JJ Chae, a true pioneer in the field of iris recognition biometrics, CMITech’s vision is to develop a range of contactless, image based biometrics products that combine outstanding usability, exceptional quality and performance with value. CMITech’s compact, robust systems are suitable for the widest range of applications, including large scale enrollment programs, immigration and border control, law enforcement, healthcare, financial services and access control.

CMITech is headquartered in Anyang, Korea and maintains its principal sales and marketing office in San Jose, California, USA. Visit http://www.cmi-tech.com.

Share article on social media or email:

BASEL, Switzerland (PRWEB)
June 04, 2020

ISO/IEC 15504 Information technology – Process assessment, also known as SPICE (Software Process Improvement and Capability dEtermination) is an international norm to assess and evaluate the maturity of business processes for software and electronic development. A process reference model defines the central processes relevant to be inspected and to be performed in any software/embedded system development. The process assessment model defines how to evaluate the capability of processes within an organization, covering the business areas of organization, management, engineering, acquisition and supply, support and operations.

Clinerion was assessed by and received ISO/ICE 15504 (SPICE) certification from the certification organization ICT Certify Test and Certifications Ltd.

“This certification is a great validation of the vital importance Clinerion places on having rigorous and meaningful business processes, in support of our work developing our software and services for the future,” says Barış Erdoğan, Vice President Site & Patient Networks, Clinerion. “Clinerion has been on this journey for a while, recently gaining ISO 27001:2013 certification, confirming that we are following best practice information security principles.”

For more information on ISO standards, please visit: http://www.iso.org.

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: http://www.clinerion.com

Clinerion’s Patient Network Explorer: https://www.clinerion.com/index/PatientNetworkExplorerSolutions.html

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

Share article on social media or email:

PETAK TIKVA, Israel (PRWEB)
June 03, 2020

Cyberint https://cyberint.com/ has been named to the CyberTech 100 – a list of the world’s most innovative providers of cybersecurity solutions for financial services firms.

CyberTech 100 recognizes those who have used innovative technology to solve a significant industry problem or to generate cost savings or efficiency improvements across the security value chain. They are selected by a panel of industry experts and analysts in a study by FinTech Global, a data and research firm. https://member.fintech.global/

Cyberint https://cyberint.com/ is a business-centric cybersecurity partner that provides intelligence-driven detection and response to digital businesses. Its unique combination of a proven technology platform and cyber and intelligence experts enables businesses to reduce their cybersecurity TCO and effectively protect what matters most to them – customers, employees, brand, and business.

Cyberint https://cyberint.com/ is one of the fastest growing sectors within the FinTech industry, with FinTech Global data showing investment in the space growing 14 times since 2014 to reach $3.4 billion last year. As financial services firms increasingly move toward digital operations and expand their security budgets, they’ll need to identify which cybersecurity providers – among the thousands – can best help them develop their information security and financial crime fighting strategies.

“Cyberint has extensive experience with financial institutions around the world,” said Itay Yanovski, Cyberint’s co-founder & SVP of strategy. “Our solution protects the FI as well as their customers’ financial and personal data across touchpoints while diligently monitoring their most pressing threats against data, operations, and processes.”

Cyberint https://cyberint.com/ provides financial institutions, including banks, insurance, and FinTech, with proactive detection and response across IT and digital environments. Cyberint’s achievements in financial services include working with the banking supervisor at Israel’s Central Bank to help create the Cyber Defense Management regulation (directive 361) for the Israeli banking sector.

“Established financial institutions need to be aware of the latest security technology in the market to protect their organizations from data leaks and cyberattacks,” said FinTech Global director Richard Sachar. “The CyberTech 100 list helps senior management filter through all the vendors in the market by highlighting the leading companies.”

A full list of the CyberTech100 can be found at http://www.CyberTech100.com.

About Cyberint

Cyberint https://cyberint.com/ provides a unique intelligence-driven detection and response solution that proactively and effectively protects businesses against cyber threats. Clients get full visibility of the threats and weaknesses in their digital environment, cloud, and associated risks from their third-party partners and receive actionable recommendations to effectively respond to threats with near-zero false positives and detailed response actions, including take downs and incident containment. Cyberint serves more than 100 brands worldwide with a unique combination of proprietary technology and cyber and intelligence analysts. https://Cyberint.com/

Follow us:

https://twitter.com/cyber_int

https://www.linkedin.com/company/cyberint

https://www.facebook.com/Cyberint/

About CyberTech 100

The CYBERTECH100 is an annual list of 100 of the world’s most innovative CyberTech companies. These are the companies every financial institution needs to know about as they consider and develop their information security and financial crime fighting strategies. The list is part of a series of studies that helps executives in financial services sort through all the noise and new suppliers to locate business models that are most likely to have a lasting impact on the industry.

Media Contact

Amy Kenigsberg

K2 Global Communications

http://k2-gc.com/

amy@k2-gc.com

tel: +972-9-794-1681 (+2 GMT)

mobile: +972-524-761-341

U.S.: +1-913-440-4072 (+7 ET)

Share article on social media or email:

JERUSALEM, Israel (PRWEB)
June 03, 2020

Cyber Armor, https://www.cyberarmor.io/, which empowers DevOps teams to seamlessly deploy natively zero-trust workloads across cloud-native and hybrid environments, has now achieved Red Hat Operator certification for OpenShift. The collaboration extends Cyber Armor’s security technology to thousands of Red Hat enterprise customers.

Cyber Armor https://www.cyberarmor.io/ cloud workload and data protection streamlines DevOps and security, providing solutions for effortless zero-trust Kubernetes clusters, CI/CD pipeline to runtime workload identity and identity-based cloud data protection. The solution removes the friction between development and security by fitting right into the existing CI/CD tools, assuring every workload going out of the pipeline is continuously verified against attacks and exploits and that only such validated, healthy state, workloads can communicate and access data.

Red Hat OpenShift, the industry’s most comprehensive enterprise Kubernetes container platform, features full-stack automated operations to manage hybrid cloud and multi-cloud deployments and is optimized to improve developer productivity and promote innovation.

“A Red Hat Certified Operator for OpenShift helps to lay the groundwork for strengthening security for an IT world built on hybrid and multi-cloud deployments, enabling OpenShift users to add zero-trust based security to their cluster with a click of a button” said Shauli Rozen, Cyber Armor CEO and Co-Founder. “We look forward to years of fruitful collaboration with Red Hat.”

“Certifying operators for OpenShift with innovative companies like Cyber Armor plays an integral role in Red Hat’s overall success,” said Lars Herrmann, senior director, technology partnerships, Red Hat. “We are proud of our part in increasing customer choice by delivering a trusted foundation for our partners’ solutions.”

About Cyber Armor

Cyber Armor https://www.cyberarmor.io/ is changing what workload security and data protection look like – driving a paradigm shift in the way companies protect their cloud native and hybrid environments. It helps companies streamline DevOps and DevSecOps, deploying environments with inherent zero-trust. Cyber Armor is headquartered in Jerusalem. http://www.cyberarmor.io

Red Hat, the Red Hat logo, and OpenShift are trademarks or registered trademarks of Red Hat, Inc. or its subsidiaries in the U.S. and other countries.

Media Contact

Amy Kenigsberg

K2 Global Communications

http://k2-gc.com/

amy@k2-gc.com

tel: +972-9-794-1681 (+2 GMT)

mobile: +972-524-761-341

U.S.: +1-913-440-4072 (+7 ET)

Share article on social media or email: